Clinical Study on TQH2722 Injection Combined With Background Therapy for Seasonal Allergic Rhinitis

Summary

This study is a multicenter, open-label, Phase II, single-arm clinical trial, with a planned enrollment of 200 to 300 subjects. Its primary objective is to evaluate the safety and efficacy of TQH2722 injection in the treatment of seasonal allergic rhinitis.

Timeline

Start

2026-03-19

Primary completion

2026-11

Completion

2027-03

Drugs

Indications